Mary F Brunette Selected Research

Dopamine D2 Receptor Antagonists

10/2019	Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.
1/2016	An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary F Brunette Research Topics

Disease

24	Schizophrenia (Dementia Praecox) 05/2022 - 10/2003
18	Mental Disorders (Mental Disorder) 03/2022 - 10/2003
11	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 10/2006
8	Substance-Related Disorders (Drug Abuse) 01/2021 - 10/2003
8	Alcoholism (Alcohol Abuse) 10/2020 - 01/2008
6	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 10/2013
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 10/2003
2	Symptom Flare Up 03/2022 - 01/2021
2	Mood Disorders (Mood Disorder) 01/2021 - 10/2013
2	Overweight 06/2015 - 12/2014
1	COVID-19 03/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Social Phobia 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 05/2015
1	Hypertension (High Blood Pressure) 12/2014
1	Insulin Resistance 12/2014
1	Prediabetic State (Prediabetes) 12/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014
1	Dyslipidemias (Dyslipidemia) 12/2014
1	Prehypertension 12/2014
1	Fatigue 08/2012
1	Sleepiness 03/2012
1	Dizziness (Lightheadedness) 03/2012
1	Dyspepsia (Indigestion) 03/2012
1	Chronic Hepatitis C 01/2006
1	Infections 01/2006
1	Virus Diseases (Viral Diseases) 01/2006

Drug/Important Bio-Agent (IBA)

11	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 10/2006
10	SmokeIBA 01/2021 - 04/2011
5	Clozapine (Clozaril)FDA LinkGeneric 10/2015 - 10/2006
3	Carbon MonoxideIBA 01/2022 - 10/2013
3	Dronabinol (THC)FDA LinkGeneric 01/2021 - 09/2014
3	Quetiapine Fumarate (Seroquel)FDA Link 01/2016 - 03/2012
2	Medical MarijuanaIBA 01/2021 - 11/2018
2	Olanzapine (Zyprexa)FDA Link 10/2020 - 12/2014
2	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 01/2008
2	Dopamine D2 Receptor AntagonistsIBA 10/2019 - 01/2016
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2017 - 01/2016
2	Naltrexone (ReVia)FDA LinkGeneric 12/2014 - 01/2008
2	Varenicline (Chantix)FDA Link 12/2014 - 07/2013
2	Bupropion (Wellbutrin)FDA LinkGeneric 12/2014 - 04/2011
2	Disulfiram (Antabuse)FDA Link 12/2014 - 01/2008
2	BenzodiazepinesIBA 02/2004 - 10/2003
1	Dihydrotachysterol (AT 10)IBA 05/2022
1	CannabinoidsIBA 01/2021
1	3-carboxamido-4-hydroxynaltrexoneIBA 10/2020
1	Nicotine FDA Link 10/2019
1	ProdrugsIBA 01/2019
1	1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA 01/2019
1	Menthol FDA Link 01/2019
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2019
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2015
1	LipidsIBA 06/2015
1	Methadone (Dolophine)FDA LinkGeneric 05/2015
1	Buprenorphine (Subutex)FDA LinkGeneric 05/2015
1	Insulin (Novolin)FDA Link 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Hemoglobins (Hemoglobin)IBA 12/2014
1	Triglycerides (Triacylglycerol)IBA 12/2014
1	Capsules (Microcapsules)IBA 09/2014
1	Levetiracetam (Keppra)FDA LinkGeneric 08/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2012
1	Acamprosate (Campral)FDA Link 01/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	Ribavirin (Virazole)FDA LinkGeneric 01/2006
1	Interferon-alpha (Interferon Alfa)IBA 01/2006
1	InterferonsIBA 01/2006
1	Diazepam (Valium)FDA LinkGeneric 02/2004

Therapy/Procedure

3	Secondary Prevention 05/2022 - 04/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2014
3	Nicotine Replacement Therapy 07/2017 - 04/2011
2	Patient Readmission 05/2022 - 04/2016
1	Continuity of Patient Care 03/2022
1	Ambulatory Care (Outpatient Care) 03/2022
1	Therapeutics 01/2021
1	Meditation 08/2017
1	Injections 10/2015
1	Combined Modality Therapy 03/2015
1	Duration of Therapy 12/2014